Byline: Marla Paul
-
New Way to Kill Lymphoma without Chemotherapy uses Golden Nanoparticles
A new study by C. Shad Thaxton, MD, and Leo Gordon, MD, shows that synthetic HDL nanoparticles killed B-cell lymphoma, the most common form of the disease, in cultured human cells.
-
In Colon Cancer, Scientists Discover ‘Two-Faced’ Cells
Northwestern Medicine researchers have discovered immune cells that can suppress or promote tumor growth in colorectal cancer, the second leading cancer killer in the United States.
-
Mobile App Boosts Weight Loss
Using a mobile app that tracks eating and activity helped people lose an average of 15 pounds and keep it off for at least a year, according to a new Northwestern Medicine study.
-
Electronic Health Records Help Spur Patients to Better Care for, Prevent Cardiovascular Disease
In a new study, Northwestern Medicine researchers found that patients at high risk for cardiovascular disease are more likely to receive a prescription for cholesterol-lowering medication, and to achieve lower long-term cholesterol levels, when doctors use electronic health records to deliver personalized risk assessments via mail.
-
Diabetics with Cancer Dangerously Ignore Blood Sugar
When people with Type 2 diabetes are diagnosed with cancer – a disease for which they are at higher risk – they ignore their diabetes care to focus on cancer treatment, according to new Northwestern Medicine research. But uncontrolled high blood sugar is more likely to kill them and impairs their immune system’s ability to…
-
Study Shows Children with Psoriasis Likely Overweight
The largest study of physician-treated children with psoriasis around the world shows children with the skin disease are about twice as likely to be overweight or obese as children who don’t have the disease, according to new Northwestern Medicine research.
-
Breakthrough Nanoparticle Halts Multiple Sclerosis
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
-
Parkinson’s Breakthrough Could Slow Neurodegenerative Disease’s Progression
Parkinson’s, the second most common neurodegenerative disease, is caused by the death of dopamine neurons, resulting in tremors, rigidity, and difficulty moving. Current treatments target the symptoms, but do not slow the progression of the disease. A new compound developed by Northwestern University scientists shows potential to halt its advancement.
-
Scientists Push for Changes to Federal Reproductive Health Research
On October 18, a team of Northwestern University scientists met with the Environmental Protection Agency to advocate for including women in reproductive health research. Much of the current research is done on men only, but the sexes often react differently to environmental toxins.
-
Novel Public Health Institute Aims to Speed Discoveries to Public
Northwestern Medicine has launched an ambitious new Institute for Public Health and Medicine that will double its faculty who work at the interface of medicine and public health with 60 additional positions and focus on improving the health of Chicagoans and other populations. It also takes a fresh approach to public health research.
